COVID-19: Renowned scientist enters clinical trial

After a career of exploring how viruses wreak havoc on our health, researcher now becomes a “subject” in a vaccine study.

New Coronascape tool will help unlock big-data insights for COVID-19

Bioinformatics platform simplifies data analysis to help biologists glean scientific insights into the novel coronavirus as body of data surges.

$11.4 million NIH grant advances drug to treat nicotine addiction

Funding awarded to scientists at Sanford Burnham Prebys, Camino Pharma and UC San Diego propels drug candidate through first-in-human studies.

Sanford Burnham Prebys receives $3 million NIH award for drugs that restore immune response to COVID-19

Scientists will study how SARS-CoV-19 hijacks the immune system and creates a “cytokine storm”